241 related articles for article (PubMed ID: 25662052)
21. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
22. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
[TBL] [Abstract][Full Text] [Related]
23. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice.
Wu HC; Lay IS; Shibu MA; Ho TJ; Cheng SM; Lin CH; Dung TD; Jeng LB; Viswanadha VP; Huang CY
Environ Toxicol; 2017 Sep; 32(9):2133-2143. PubMed ID: 28548306
[TBL] [Abstract][Full Text] [Related]
24. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.
Condorelli G; Drusco A; Stassi G; Bellacosa A; Roncarati R; Iaccarino G; Russo MA; Gu Y; Dalton N; Chung C; Latronico MV; Napoli C; Sadoshima J; Croce CM; Ross J
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12333-8. PubMed ID: 12237475
[TBL] [Abstract][Full Text] [Related]
25. Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt/β-catenin signaling.
Martherus R; Jain R; Takagi K; Mendsaikhan U; Turdi S; Osinska H; James JF; Kramer K; Purevjav E; Towbin JA
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H174-87. PubMed ID: 26545710
[TBL] [Abstract][Full Text] [Related]
26. DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin.
Mitra A; Menezes ME; Pannell LK; Mulekar MS; Honkanen RE; Shevde LA; Samant RS
Oncogene; 2012 Oct; 31(41):4472-83. PubMed ID: 22266849
[TBL] [Abstract][Full Text] [Related]
27. HSP105 recruits protein phosphatase 2A to dephosphorylate β-catenin.
Yu N; Kakunda M; Pham V; Lill JR; Du P; Wongchenko M; Yan Y; Firestein R; Huang X
Mol Cell Biol; 2015 Apr; 35(8):1390-400. PubMed ID: 25645927
[TBL] [Abstract][Full Text] [Related]
28. Ablation of periostin inhibits post-infarction myocardial regeneration in neonatal mice mediated by the phosphatidylinositol 3 kinase/glycogen synthase kinase 3β/cyclin D1 signalling pathway.
Chen Z; Xie J; Hao H; Lin H; Wang L; Zhang Y; Chen L; Cao S; Huang X; Liao W; Bin J; Liao Y
Cardiovasc Res; 2017 May; 113(6):620-632. PubMed ID: 28453729
[TBL] [Abstract][Full Text] [Related]
29. Cardiac function is regulated by B56α-mediated targeting of protein phosphatase 2A (PP2A) to contractile relevant substrates.
Kirchhefer U; Brekle C; Eskandar J; Isensee G; Kučerová D; Müller FU; Pinet F; Schulte JS; Seidl MD; Boknik P
J Biol Chem; 2014 Dec; 289(49):33862-73. PubMed ID: 25320082
[TBL] [Abstract][Full Text] [Related]
30. Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice.
Adluri RS; Thirunavukkarasu M; Zhan L; Akita Y; Samuel SM; Otani H; Ho YS; Maulik G; Maulik N
J Mol Cell Cardiol; 2011 Jan; 50(1):239-47. PubMed ID: 21074540
[TBL] [Abstract][Full Text] [Related]
31. Dopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function.
Zhang Y; Jiang X; Qin C; Cuevas S; Jose PA; Armando I
Am J Physiol Renal Physiol; 2016 Jan; 310(2):F128-34. PubMed ID: 26290374
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
33. Cardiomyocyte specific deletion of PP2A causes cardiac hypertrophy.
Li L; Fang C; Xu D; Xu Y; Fu H; Li J
Am J Transl Res; 2016; 8(4):1769-79. PubMed ID: 27186301
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
[TBL] [Abstract][Full Text] [Related]
36. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway.
Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I
Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844
[TBL] [Abstract][Full Text] [Related]
37. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
[TBL] [Abstract][Full Text] [Related]
38. Over-expression of calpastatin inhibits calpain activation and attenuates post-infarction myocardial remodeling.
Ye T; Wang Q; Zhang Y; Song X; Yang D; Li D; Li D; Su L; Yang Y; Ma S
PLoS One; 2015; 10(3):e0120178. PubMed ID: 25786109
[TBL] [Abstract][Full Text] [Related]
39. CHIP enhances angiogenesis and restores cardiac function after infarction in transgenic mice.
Xu CW; Zhang TP; Wang HX; Yang H; Li HH
Cell Physiol Biochem; 2013; 31(2-3):199-208. PubMed ID: 23485987
[TBL] [Abstract][Full Text] [Related]
40. Activation of Wnt/β-catenin/GSK3β signaling during the development of diabetic cardiomyopathy.
Xi XH; Wang Y; Li J; Wang FW; Tian GH; Yin MS; Mu YL; Chong ZZ
Cardiovasc Pathol; 2015; 24(3):179-86. PubMed ID: 25586361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
